1. Acknowledgement to Referees

   Acknowledgement to Referees 22 November 2014 Pages: 401 - 402

2. Novel Therapeutic Targets in the Management of Atrial Fibrillation

   • Abhishek Maan
   • Moussa Mansour
   • E. Kevin Heist

   Review Article 05 August 2014 Pages: 403 - 421

   

3. Thiazide-Like/Calcium Channel Blocker Agents: A Major Combination for Hypertension Management

   • M. E. Safar
   • J. Blacher

   Review Article 28 August 2014 Pages: 423 - 432

   

4. The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway

   • Hong Yao
   • Xiangyang Han
   • Xiuzhen Han

   Review Article 27 August 2014 Pages: 433 - 442

   

5. Patterns in the Use of Low-Dose Acetylsalicylic Acid and Other Therapies Following Upper Gastrointestinal Bleeding

   • María E. Sáez
   • Antonio González-Pérez
   • Luis A. García Rodríguez

   Original Research Article 14 August 2014 Pages: 443 - 450

   

6. Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings

   • Talitha I. Verhoef
   • William K. Redekop
   • Anke Hilse Maitland-van der Zee

   Original Research Article Open access 18 October 2014 Pages: 451 - 462

   

7. Epoprostenol (Veletri^®, Caripul^®): A Review of Its Use in Patients with Pulmonary Arterial Hypertension

   • Sarah L. Greig
   • Lesley J. Scott
   • Greg L. Plosker

   Adis Drug Evaluation 14 October 2014 Pages: 463 - 470

   

8. Icosapent Ethyl: A Review of Its Use in Severe Hypertriglyceridemia

   • Esther S. Kim
   • Paul L. McCormack

   Adis Drug Evaluation 27 November 2014 Pages: 471 - 478